Your browser doesn't support javascript.
loading
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Blons, H; Emile, J F; Le Malicot, K; Julié, C; Zaanan, A; Tabernero, J; Mini, E; Folprecht, G; Van Laethem, J L; Thaler, J; Bridgewater, J; Nørgård-Petersen, L; Van Cutsem, E; Lepage, C; Zawadi, M A; Salazar, R; Laurent-Puig, P; Taieb, J.
Afiliação
  • Blons H; UMR-S1147, INSERM, Paris; Paris Descartes University, Paris; APHP Department of Biology, Georges Pompidou Hospital, Paris.
  • Emile JF; Department of Pathology, APHP Ambroise Paré Hospital, Boulogne-Billancourt; Paris-Ouest University, Versailles Saint-Quentin.
  • Le Malicot K; Department of Statistics, Fédération Francophone de Cancérologie Digestive, Dijon.
  • Julié C; Department of Pathology, APHP Ambroise Paré Hospital, Boulogne-Billancourt.
  • Zaanan A; APHP Department of Hepatogastroenterology and GI Oncology, Georges Pompidou Hospital, Paris, France.
  • Tabernero J; Department of Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
  • Mini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Folprecht G; 1st Medical Department, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Van Laethem JL; Deptartment of Gastroenterology, Erasme University Hospital, Brussels, Belgium.
  • Thaler J; Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria.
  • Bridgewater J; UCL Cancer Institute, University College London, London, UK.
  • Nørgård-Petersen L; Department of Oncology, Rigshospitalet, København, Denmark.
  • Van Cutsem E; Department of Digestive Oncology, University Hospitals and KULeuven, Leuven, Belgium.
  • Lepage C; Department of Hepato-Gastroenterology, Dijon University Hospital and INSERM U 866, Dijon.
  • Zawadi MA; GI Oncology, Les Oudairies Hospital, La Roche sur Yon, France.
  • Salazar R; Catalan Institute of Oncology (IDIBELL), Barcelona, Spain.
  • Laurent-Puig P; UMR-S1147, INSERM, Paris; Paris Descartes University, Paris; APHP Department of Biology, Georges Pompidou Hospital, Paris.
  • Taieb J; APHP Department of Hepatogastroenterology and GI Oncology, Georges Pompidou Hospital, Paris, France; Paris Descartes University, Paris. Electronic address: julien.taieb@egp.aphp.fr.
Ann Oncol ; 25(12): 2378-2385, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25294886
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Genes ras / Neoplasias do Colo / Mutação Tipo de estudo: Prognostic_studies Idioma: En Revista: Ann Oncol Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Genes ras / Neoplasias do Colo / Mutação Tipo de estudo: Prognostic_studies Idioma: En Revista: Ann Oncol Ano de publicação: 2014 Tipo de documento: Article